Usv UK
UK pharmaceutical subsidiary supplying and distributing medicines, including its own-label products, to the UK market
Highlights
- New on EvolcAdded 2026-11-01
About Usv UK
USV UK Limited commercializes medicines in the UK, including solid oral medicines, injectables and eye drops. It holds marketing authorisations and supports importing, warehousing, batch testing and release through a Qualified Person.
The company sells products under its own label and works with marketing and distribution partners, including under an own-label supply model. Its product range includes medicines for diabetes and other therapeutic areas.
Founded in 2008, USV UK is headquartered in London and is a wholly owned subsidiary of India-based USV Private Limited.
Product: Commercializes pharmaceutical products in the UK and provides importing, warehousing, batch testing and release services.
Jobs at Usv UK
More biotech & pharma companies
Valid Insight
Market access consultancy helping pharma, biotech and medtech companies with payer strategy, pricing and launch evidenceNew on EvolcValneva UK
Develops and supplies travel vaccines and clinic support for healthcare providersNew on EvolcVector Futures
AI-guided genetic engineering and contract research for biological product developersYoung companyNew on EvolcVedaly
AI research platform and data consulting for biopharma R&D and translational teamsYoung companyNew on EvolcVeramed
Clinical trial biometrics services (data management, biostatistics, programming) for pharma and biotech sponsorsNew on EvolcRemote-friendlyVerdiva Bio
Develops once-weekly peptide medicines for obesity and cardiometabolic disease, with a lead drug in Phase 2 trialsYoung companyNew on Evolc
Website technologies
Tools and platforms detected on this company’s website, grouped by purpose. Dates record when Evolc observed them.
Analytics
- Google Analytics 4High confidence
- First detected
- Last detected
- Last checked
Detection evidence
- Website resourcedeclared script/iframe or software asset
Website detection does not establish a paid subscription or company-wide use. Tools loaded after consent or sign-in may be missed. “No longer observed” does not prove the company stopped using a tool.